OCEA.US Ocean Biomedical Inc.

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 16, 2026
Market cap
USD 23.2K
P/E
-
P/B
100.67x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2025.

Is OCEA.US undervalued?

Graham number

The Graham number of Ocean Biomedical Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ocean Biomedical Inc. fundamental analysis

No fundamental analysis for Ocean Biomedical Inc. yet.

Ocean Biomedical Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ocean Biomedical Inc.

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product cand…

Full company profile